Search results
CVS COVID-19 Vaccine Near Ashburn VA
www.cvs.comPharmacy LocationBy appointment only44835 Russel Branch Parkway(571) 223-000623684 Strickland Drive(571) 367-603921170 Ashby Ponds Blvd(571) 293-716943930 Farmwell Hunt Plaza(703) 724-7582Dec 11, 2020 · COMIRNATY is the first COVID-19 vaccine to be granted FDA approval Approval is based on a comprehensive submission package including six-month efficacy and safety data after second dose More than 1.2 billion Pfizer-BioNTech doses have been delivered to more than 120 countries or territories around the world since December 2020 Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today ...
Preparation. If the vaccine is frozen, thaw before use. Check the vial or syringe label to ensure the expiration date or BUD (if applicable) has not passed. Use Pfizer-BioNTech expiration date tool at lotexpiry. cvdvaccine.com Product for ages 6 months through 4 years: mix with diluent. Mix vial with 1.1 mL diluent.
Sep 11, 2023 · The Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) includes a monovalent (single) component that corresponds to the Omicron variant XBB.1.5 of SARS-CoV-2. The Pfizer-BioNTech COVID-19 ...
- What You Need to Know
- Recommendations for Everyone Aged 5 Years and Older
- Recommendations for Children Aged 6 Months—4 Years
- Recommendation for People Who May Get Additional Updated COVID-19 Vaccines
- When Are You Up to Date?
- How Well COVID-19 Vaccines Work
- About COVID-19 Vaccines
- Getting Vaccines If You Recently Had COVID-19
- Vaccination Received Outside the United States
•CDC recommends the 2023–2024 updated COVID-19 vaccines: Pfizer-BioNTech, Moderna, or Novavax, to protect against serious illness from COVID-19.
•Everyone aged 5 years and older ‡ should get 1 dose of an updated COVID-19 vaccine to protect against serious illness from COVID-19.
•Children aged 6 months–4 years need multiple doses of COVID-19 vaccines to be up to date, including at least 1 dose of updated COVID-19 vaccine.
•People who are moderately or severely immunocompromised may get additional doses of updated COVID-19 vaccine.
•COVID-19 vaccine recommendations will be updated as needed.
•People who are up to date have lower risk of severe illness, hospitalization and death from COVID-19 than people who are unvaccinated or who have not completed the doses recommended for them by CDC.
Children aged 5 years – 11 years who are not vaccinated or have gotten previous COVID-19 vaccine(s)
Children aged 5 years – 11 years who are unvaccinated or have previously gotten a COVID-19 vaccine before September 12, 2023, should get 1 updated Pfizer-BioNTech or Moderna COVID-19 vaccine.
People aged 12 years and older who are not vaccinated
Moderna Novavax
People aged 12 years and older who got previous COVID-19 vaccine(s)
Vaccine Overview Learn more about COVID-19 vaccines Pfizer-BioNTech VaccineModerna VaccineNovavax Vaccine ‡12 years and older: People aged 12 years and older who have not previously gotten any COVID-19 vaccine doses and choose to get Novavax should get 2 doses of updated Novavax vaccine to be up to date.
Children Who Are Not Vaccinated
Pfizer-BioNTech Vaccine Overview Moderna Moderna Vaccine Overview
Children Who Got Previous COVID-19 Vaccine(s)
One Previous Dose Two or More Previous Doses Pfizer-BioNTech Vaccine Overview Moderna One Previous Dose Two or More Previous Doses Moderna Vaccine Overview
People who are moderately or severely immunocompromised may get additional doses of updated COVID-19 vaccines. Talk to your healthcare provider about additional updated doses.
Everyone aged 5 years and older
You are up to date when you get 1 updated COVID-19 vaccine.‡
Children aged 6 months—4 years
You are up to date when you get all recommended doses, including at least 1 dose of updated COVID-19 vaccine.
People who got the Johnson & Johnson/Janssen COVID-19 vaccine
You are up to date when you get 1 updated COVID-19 vaccine.
•People who are up to date have lower risk of severe illness, hospitalization and death from COVID-19 than people who are unvaccinated or who have not completed the doses recommended for them by CDC.
•Additional updated COVID-19 vaccine doses can help restore protection that has decreased since previous vaccination.
COVID-19 vaccines available in the United States are effective at protecting people from getting seriously ill, being hospitalized, and dying. As with other vaccine-preventable diseases, you are best protected from COVID-19 when you stay up to date with the recommended vaccinations.
COVID-19 vaccines recommended for use in the United States:
•Pfizer-BioNTech
•Moderna
If you recently had COVID-19, you still need to stay up to date with your vaccines, but you may consider delaying your vaccine by 3 months.
Reinfection is less likely in the weeks to months after infection. However, certain factors could be reasons to get a vaccine sooner rather than later, such as:
•personal risk of severe disease,
•risk of disease in a loved one or close contact,
•local COVID-19 hospital admission level,
•and the most common COVID-19 variant currently causing illness.
For Healthcare and Public Health
Use of COVID-19 Vaccines in the United States: Interim Clinical Considerations Last Updated Jan. 18, 2024 Source: National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [30] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing. [42] [43] It is authorized for use ...
- Comirnaty
- mRNA
Aug 23, 2021 · The first EUA, issued Dec. 11, for the Pfizer-BioNTech COVID-19 Vaccine for individuals 16 years of age and older was based on safety and effectiveness data from a randomized, controlled, blinded ...
This product information is intended only for residents of the United States. Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) has not been approved or licensed by FDA, but has been authorized for emergency use by FDA, under an EUA to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals 6 months through 11 years of age. The emergency use of this product is only authorized for ...